Pershing Square Holdings authorized a $100 million repurchase window. ABN AMRO committed €250 million. Amadeus launched €13.325 million. Three programs, three jurisdictions, seventy-two hours.
Pershing Square Holdings—Bill Ackman's closed-end vehicle trading in Amsterdam and London—announced authorization on May 19. The $100 million program runs through November 2026 and applies to both ordinary shares and special voting shares. The vehicle closed May 16 at a 9.8% discount to net asset value. ABN AMRO's supervisory board approved €250 million in buybacks on May 20, part of a broader €500 million capital return framework extending into late 2025. The Dutch bank holds a common equity Tier 1 ratio of 14.2%, 190 basis points above regulatory minimums. Amadeus IT Group—Spanish travel tech infrastructure provider—green-lit €13.325 million under its existing authorization, targeting shares for employee compensation plans rather than cancellation. Execution begins May 21 and runs through June 30.
The simultaneity matters less than the divergence in motivation. Pershing Square's move addresses persistent NAV discount compression—the vehicle has traded 8-12% below intrinsic value for eleven consecutive months despite underlying portfolio marks rising 14% year-over-year. Ackman telegraphed this in Q1 letters, noting structural dislocation in closed-end fund pricing when anchor positions lack near-term catalysts. ABN AMRO's authorization reflects excess capital generation in a flattening European rate environment—the bank posted €1.73 billion in net profit for 2024, up 22% from prior year, while loan growth stalled at 1.4%. With Basel IV implementation deferred to January 2026 and no material M&A pipeline disclosed, buybacks become the default capital deployment lever. Amadeus operates differently: the €13.325 million tranche funds restricted stock units vesting in Q3 2025, avoiding dilution from equity compensation rather than signaling undervaluation.
The structure of each program reveals board confidence levels. Pershing Square's eighteen-month authorization with no dollar-cost-averaging mandate suggests Ackman sees episodic entry points rather than systematic underpricing. ABN AMRO's phased approach—€250 million now, €250 million reserved pending H2 capital generation—hedges against regulatory recalibration or credit deterioration. Amadeus caps the program at 0.25% of shares outstanding, treating it as operational plumbing rather than strategic recapitalization. None disclosed price ceilings or volume-weighted average price mechanisms, implying discretionary execution through brokers rather than algorithmic deployment.
Watch ABN AMRO's Q2 earnings call in August for commentary on the second €250 million tranche release timing. Pershing Square's September NAV publication will show whether discount compression follows initial repurchases or persists despite capital allocation signals. Amadeus vesting schedules finalize by June 30—if the program extends beyond employee grants, it signals management sees tactical value below €68 per share, the May 20 close.
Three programs. Three balance sheet postures. One shared arithmetic: internal rate of return on buybacks exceeds marginal deployment alternatives. The boards named their number.